New Device Makes Drawing Blood And Inserting IVs Less Traumatic For Patients Of All Ages
9/08/2011
Sinai Hospital, Northwest Hospital and Levindale Hebrew Geriatric Center and Hospital, LifeBridge Health centers in Baltimore, Md., have begun using the AccuVein AV300, a revolutionary new device that makes drawing blood and inserting IVs a less painful experience for patients...
Blood Test And Algorithm For Ovarian Cancer Developed By Oncologist, Cleared By FDA
9/08/2011
Approval last week by U.S. Food and Drug Administration (FDA) clears the path for nationwide use of tools that show the greatest specificity in estimating the risk of ovarian cancer in women with a pelvic mass. The FDA granted 510(k) clearance for marketing and use of a combination of blood tests for proteins HE4 and CA125 with the Risk of Ovarian Malignancy Algorithm (ROMA™)...
Screening For HPV Persistence And Cervical Cancer Risk
9/08/2011
Women over the age of thirty who test positive for HPV (Human Papillomavirus) should be re-tested two years later as part of cervical cancer screening, according to a study published online TK in the Journal of the National Cancer Institute...
Cervical Cancer Prevention And Modeling Disparities
9/08/2011
Researchers reported that explicit inclusion of disparities in cost-effectiveness analysis, would allow policy makers to identify strategies that would reduce overall cancer risk, reduce disparities between racial ethnic subgroups, and be cost-effective, according to a study published online September 6 in the Journal of the National Cancer Institute...
Chemotherapy Can Impair Speech
9/08/2011
Patients who have received high doses of chemotherapy may find it harder to express themselves verbally, according to new research from the Sahlgrenska Academy at the University of Gothenburg, Sweden. Speech difficulties among cancer patients who received chemotherapy treatment were two times higher than among those who did not...
The Role Of Alcohol Intake And Smoking On Upper Aero-Digestive Cancers
9/08/2011
This paper provides an extensive analysis of the proportion of the risk of upper aero-digestive tract (UADT) cancers in the population (the population attributable risk) that may be due to alcohol consumption and/or smoking...
Blood Test And Algorithm For Ovarian Cancer Developed By Oncologist, Cleared By FDA
9/08/2011
Approval last week by U.S. Food and Drug Administration (FDA) clears the path for nationwide use of tools that show the greatest specificity in estimating the risk of ovarian cancer in women with a pelvic mass. The FDA granted 510(k) clearance for marketing and use of a combination of blood tests for proteins HE4 and CA125 with the Risk of Ovarian Malignancy Algorithm (ROMA™)...
Screening For HPV Persistence And Cervical Cancer Risk
9/08/2011
Women over the age of thirty who test positive for HPV (Human Papillomavirus) should be re-tested two years later as part of cervical cancer screening, according to a study published online TK in the Journal of the National Cancer Institute...
Cervical Cancer Prevention And Modeling Disparities
9/08/2011
Researchers reported that explicit inclusion of disparities in cost-effectiveness analysis, would allow policy makers to identify strategies that would reduce overall cancer risk, reduce disparities between racial ethnic subgroups, and be cost-effective, according to a study published online September 6 in the Journal of the National Cancer Institute...
Nearly half of breast cancer patients carrying the BRCA1 gene mutation experience a complete pathological response (pCR) - the disappearance of all evidence of disease from the breast tissue and lymph nodes - regardless of disease stage after standard neoadjuvent chemotherapy, according to new research from The University of Texas MD Anderson Cancer Center...